The Effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

October 5, 2018 updated by: Kang Yan
The purpose of this study is to investigate the effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

220

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • China
    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • Recruiting
        • West China Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients in ICU who need enteral nutrition,and the length of stay in icu>3days

Description

Inclusion Criteria:

All patients who need enteral nutrition (through the nose) in ICU ; the length of stay in ICU > 3 days;

Exclusion Criteria:

<18 years old; >90 years old; gastrointestinal surgery history； small blow nutrition； BMI>30kg/m2; pregnancy; prone position>4hours a day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of tube feeding intolerance during ICU
Time Frame: during ICU,an average of 7 days
incidence of tube feeding intolerance during ICU，such as vomit，diarrhea，Bloating.
during ICU,an average of 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gastric residual volume
Time Frame: during ICU,an average of 7 days
gastric residual volume during ICU
during ICU,an average of 7 days
nutrition indicators
Time Frame: through study completion,an average of 7 days
nutrition indicators during ICU,such as prealbumin
through study completion,an average of 7 days
the first clinical parameters of prognosis
Time Frame: through study completion,an average of 7 days
incidence of regurgitation during enteral nutrition
through study completion,an average of 7 days
the second clinical parameters of prognosis
Time Frame: through study completion,an average of 7 days
ventilator-associated pneumonia
through study completion,an average of 7 days
the third clinical parameters of prognosis
Time Frame: through study completion,an average of 7 days
length of mechanic ventilation during ICU
through study completion,an average of 7 days
the forth clinical parameters of prognosis
Time Frame: through study completion,an average of 7 days
length of stay in ICU
through study completion,an average of 7 days
the fifth clinical parameters of prognosis
Time Frame: through study completion,an average of 15 days
hospital mortality
through study completion,an average of 15 days
the sixth clinical parameters of prognosis
Time Frame: through study completion,an average of 7 days
hospitalization costs during ICU
through study completion,an average of 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kang Yan

Collaborators

First Affiliated Hospital, Sun Yat-Sen University
Beijing Tongren Hospital
Beijing Tsinghua Chang Gung Hospital
Zhongda Hospital
First Hospital of China Medical University

Investigators

  • Study Chair: Yuan Xu, M.D., Beijing Tsinghua Changgeng Hospital
  • Study Chair: Wei He, Beijing Tongren Hospital
  • Study Chair: Yi Yang, Zhongda Hospital
  • Study Chair: Bin Ouyang, The first affiliation hospital,Sun Yat-sen university
  • Study Chair: Ran Zhu, First Hospital of China Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

July 1, 2019

Study Registration Dates

First Submitted

April 23, 2018

First Submitted That Met QC Criteria

May 16, 2018

First Posted (Actual)

May 29, 2018

Study Record Updates

Last Update Posted (Actual)

October 9, 2018

Last Update Submitted That Met QC Criteria

October 5, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GUS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe